Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17097
Country/Region: Malawi
Year: 2016
Main Partner: Project Concern International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USDOD
Total Funding: $1,580,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $160,000
Care: TB/HIV (HVTB) $50,000
Strategic Information (HVSI) $50,000
Health Systems Strengthening (OHSS) $50,000
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $85,000
Testing: HIV Testing and Counseling (HVCT) $125,000
Sexual Prevention: Other Sexual Prevention (HVOP) $150,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $120,000
Treatment: Adult Treatment (HTXS) $690,000
Treatment: Pediatric Treatment (PDTX) $100,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,387
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 728
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 9,324
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 6,246
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 17,685
HTS_TST Service Delivery Point (Facility): Other PITC 2017 683
HTS_TST Service Delivery Point (Facility): Outpatient 2017 1,130
HTS_TST Service Delivery Point (Facility): PMTCT 2017 617
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 199
HTS_TST Service Delivery Point (Facility): VCT 2017 15,056
HTS_TST Sum of Aggregated Age/Sex <15 2017 2,115
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 15,570
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 17,685
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 106
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 94
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 661
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 765
PMTCT_ART New on ART 2017 60
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 617
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 59
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 3
PMTCT_EID Sum of Infant Age disaggregates 2017 59
PMTCT_STAT By: Number of new positives identified 2017 62
PMTCT_STAT Number of new ANC and L&D clients 2017 687
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 617
PMTCT_STAT Sum of Positives Status disaggregates 2017 62
PP_PREV Aggregated Age/sex: <15 Female 2017 1,706
PP_PREV Aggregated Age/sex: <15 Male 2017 1,964
PP_PREV Aggregated Age/sex: 15+ Female 2017 13,065
PP_PREV Aggregated Age/sex: 15+ Male 2017 15,163
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 31,898
PP_PREV Total number of people in the target population 2017 89,963
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 3,361
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 2,980
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 335
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 297
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 6,973
TX_CURR Aggregated Age/Sex: <15 Female 2017 352
TX_CURR Aggregated Age/Sex: <15 Male 2017 312
TX_CURR Aggregated Age/Sex: 15+ Female 2017 3,538
TX_CURR Aggregated Age/Sex: 15+ Male 2017 3,137
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 7,340
TX_CURR Sum of Aggregated Age/Sex <15 2017 664
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 6,675
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 7,339
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 98
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 87
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 710
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 629
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,524
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,524
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 78
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 69
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 568
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 503
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,219
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,339
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 98
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 87
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 710
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 629
Cross Cutting Budget Categories and Known Amounts Total: $30,000
Gender: Gender Based Violence (GBV) $20,000
GBV Prevention
Implementation
Capacity building
Post GBV Care
Implementation
Capacity building
Condoms: Policy, Tools, and Services $10,000